Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MVRBF:US

10.2300 USD 0.7800 8.25%

As of 20:10:00 ET on 04/16/2015.

Snapshot for Medivir AB (MVRBF)

Open: 10.2300 Day's Range: 10.2300 - 10.2300 Volume: 125
Previous Close: 9.4500 52wk Range: 9.4500 - 20.3000 1-Yr Rtn: -34.05%

Stock Chart for MVRBF

No chart data available.
  • MVRBF:US 10.2300
  • 1M
  • 1Y
9.4500
Interactive MVRBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MVRBF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 10.9207
Relative P/E vs. SPX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2015) 8.1080
Est. PEG Ratio -
Market Cap (M USD) 349.97
Shares Outstanding (M) 26.36
30 Day Average Volume 15
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/05/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MVRBF

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MVRBF

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Niklas PragerPresident/CEOOla BurmarkCFO
Richard BethellExec VP:Discovery ResearchHenrik KrookExec VP:Commercial
More Company Profile & Key Executives for MVRBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil